Jiritano, Federica
Serraino, Giuseppe Filiberto
ten Cate, Hugo
Fina, Dario
Matteucci, Matteo
Mastroroberto, Pasquale
Lorusso, Roberto
Article History
Received: 20 November 2019
Accepted: 28 March 2020
First Online: 23 April 2020
Compliance with ethical standards
:
: Prof. Dr. Roberto Lorusso is consultant for LivaNova (principal investigator of PERSIST-AVR Trial) and Medtronic. Prof. Dr. Hugo ten Cate receives research funding from Bayer and Pfizer.